New Product Development
The global drug-induced dyskinesia market is on an impressive growth trajectory, with recent market analysis forecasting a significant valuation of USD 399.8 million by the end of 2023. Further projections indicate the market will expand to a notable USD 620.2 million by 2033, reflecting a steady compound annual growth rate (CAGR) of 4.25% over the …
Continue reading “Global Drug-Induced Dyskinesia Market Poised to Reach USD 620.2 Million by 2033”
The global drug-induced dyskinesia market is witnessing remarkable growth, according to the latest market analysis. Projections indicate a trajectory leading to a notable milestone of USD 399.8 million by fiscal year 2023, with further anticipated growth to USD 620.2 million by 2033. The findings, based on comprehensive market research, reveal a compound annual growth rate (CAGR) of …
In the year 2022, the global drug-induced dyskinesia market was estimated to be worth US$ 382 Million. Considering the rising demand in the global market, it is predicted to reach a valuation of US$ 399.8 Million by 2023. The market will also exhibit a steady CAGR of 4.25% from 2023-2033 and hence ultimately reach US$ …